期刊文献+

冠状动脉粥样硬化与AMPK、SIRT1基因表达的关系初步研究 被引量:1

Preliminary research of the relationship between coronary artery atherosclerosis and the genetic expression of AMPK and SIRT1
下载PDF
导出
摘要 目的:通过检测冠状动脉粥样硬化患者外周血单个核细胞(PBMC)中单磷酸腺苷激活的蛋白激酶(AMPK)以及沉默信息调节因子2相关酶I(SIRT1)的基因表达情况,初步探讨AMPK和SIRT1基因表达与冠状动脉粥样硬化形成以及调控血浆中一氧化氮(NO)水平、血脂、血糖代谢的可能机制。方法:利用普通PCR、琼脂糖凝胶电泳、实时荧光定量PCR及SPSS分析软件检测冠心病者和正常对照组外周血单个核细胞(PBMC)中AMPK和SIRT1的基因表达区别,以及它们与血脂(TC、TG、LDL-c、HDL-c)、空腹血糖(FBG)、一氧化氮(NO)含量的相关性。结果:冠心病组PBMC中AMPK和SIRT1基因表达以及血浆中NO含量均明显低于对照组,差异具有统计学意义(P均<0.05)。AMPK和SIRT1表达均与TC、TG、LDL-c、FBG呈负相关,与NO含量及HDL-c呈正相关(P均<0.05)。结论:冠心病患者PBMC中AMPK和SIRT1基因表达下降可能与冠心病的发病存在相关性,对调控血脂、血糖及NO生成释放中可能起到一定作用。 Objective:To explore the adenosine monophosphate activated protein kinase(AMPK) and silent information regulator 1(SIRT1)gene expression involved in the progression of coronary heart disease,and the possible metabolic mechanism of controlling the serum nitric oxide(NO),lipid and glucose levels in patients with coronary artery disease patients through the detection of gene expression of(AMPK)and(SIRT1)of the peripheral blood mononuclear cell(PBMC).Methods:Detecting the differences in the PBMC genetic expression of AMPK and SIRT1between disease group and control group by ordinary PCR,agarose electrophoresis,and real-time fluorescence quantification methods.Statistical analysis was performed with SPSS 18.0software.Correlation between AMPK,SIRT1gene expression and the other atherosclerosis related factors including lipid,fasting blood glucose,nitric oxide were analyzed.Results:Gene expression of AMPK,SIRT1and serum nitic oxide concentration of the disease group was significantly decreased compared with the control group(Pall0.05).AMPK and SIRT1gene expression were negatively correlated with TC、TG、LDL-c、and FBG,while positively correlated with NO,HDL-c(P all0.05).Conclusions:Decreased expression of AMPK and SIRT1gene are correlated with the occurrence of the coronary heart disease indicating they play a role in controlling blood lipid,glucose and the generation of nitric oxide.
出处 《海南医学院学报》 CAS 2013年第10期1349-1353,共5页 Journal of Hainan Medical University
基金 广东省科技计划项目:(2011B080701073)~~
关键词 单磷酸腺苷激活的蛋白激酶 沉默信息调节因子2相关酶I 冠心病 一氧化氮 AMPK SIRT1 Coronary heart disease Nitric oxide
  • 相关文献

参考文献16

  • 1Hardie DG Carling D.The AMP-activated protein ki-nase-fuel gauge of the mammalian cell[J].Eur J Bio-chem,1997,246:259-273.
  • 2Shaw RJ,Lamia KA,Vasquez D,et al.The kinaseLKB1mediates glucose homeostasis in liver and thera-peutic effects of metformin[J].Science,2005,310:1642-1646.
  • 3Finkel T,Deng CX,Mostoslavsky R,et al.Recentprogress in the biology and physiology of sirtuins[J].Nature,2009,460:587-591.
  • 4McGee SL,Hargreaves M.AMPK and transcriptionalregulation[J].Front Biosci,2008,13:3022-3033.
  • 5Zhao Zhong Chong,Shaohui Wang,Shang YC,et al.Targeting Cardiovascular Disease with Novel SIRT1Pathways[J].Future Cardiol,2012,8(1):89–100.
  • 6田云霄,赵静雅.SIRT1和E2F1的研究进展[J].实用心脑肺血管病杂志,2012,20(6):951-956. 被引量:7
  • 7Marcia CH,Leonard PG.Mammalian sirtuins-emergingroles in physiology aging and calorie restriction[J].GenDev,2008,20(21):2913-2921.
  • 8Guarani V,Potente M.SIRT1-a metabolic sensor thatcontrols blood vessel growth[J].Current Opinion inPharmacology,2010,10:139–145.
  • 9Carles Canto',Zachary Gerhart-Hines,Feige JN,et al.AMPK regulates energy expenditure by modulatingNAD metabolism and SIRT1activity[J].Nature,2009,458(23):1056-1061.
  • 10Xiuyun Hou,Shanqin Xu,Sato K,et al.SIRT1Regu-lates Hepatocyte Lipid Metabolism through ActivatingAMP-activated Protein Kinase[J].Journal of BiolChem,2008,283(29):20015–20026.

二级参考文献42

  • 1陈丽函,王伟,傅玉才,李吉林,许铭炎.白藜芦醇对缺血再灌注心肌细胞凋亡及沉寂信息调节因子2表达的影响[J].中国临床康复,2006,10(19):69-71. 被引量:15
  • 2Dirks A J, Leeuwenhburgh C. Tumor necrosis factor alpha signa - ling in skeletalmuscle: effects of age and caloric restriction [ J ]. J Nutr Biochem, 2006, 17 (8) : 501-508.
  • 3Wang C, Chen L, Hou X, et al. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage [ J]. Nat Cell Biol, 2006, 8 (9): 1025-1031.
  • 4Hehweg B, Gatbonton T, Schuler AD, et al. Antitumor activity of a small - molecule inhibitor of human silent information regulator 2 en- zymes [J]. Cancer Res, 2006, 66 (8): 4368-4377.
  • 5Vaquero A, Scher M, Lee D, et al. Human SirT1 interacts with his- tone H1 and promotes formation of facultative heterochromatin [ J]. Mol Cell, 2004, 16 (1): 93-105.
  • 6Pruitt K, Zinn RL, Ohm JE, et al. Inhibition of SIRT1 reactivates si- lenced cancer genes without loss of promoter DNA heper methylation [J]. PLoS Genet, 2006, 2 (30): 32-40.
  • 7Kikuno N, Shiina H, Urakami S, et al. Genistein mediated histone acetylation and demethylation activates tumour suppressor genes in pros- tate cancer clls [J]. Int J Cancer, 2008, 123 (3) : 552 -560.
  • 8Bode AM, Dong Z. Post - translational modification of p53 in tumori- genesis [J]. Nat Rev Cancer, 2004, 4 (10): 793-805.
  • 9Chen LF, Greene WC. Shaping the nuclear action of NF - kappaB [J]. Nat Rev Mol Cell Biol, 2004, 5 (5) : 392 -401.
  • 10Yang Y, Hou H, Hailer EM, et al. by FHL2 through SIRTI - mediated 2005, 24 (5) : 1021 -1032.

共引文献6

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部